SP

Siva Pradeep Yanamadala

Active Director Designated Partner DIN 11541779
DIN 11541779 First appointment Feb 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Siva Pradeep Yanamadala

Data last updated:

Siva Pradeep Yanamadala is a Designated Partner at Q-Therapeutics Llp (since 2026).

DIN 11541779
Primary Designation Designated Partner
First Appointment 12 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner12 Feb 20262026Active

Board colleagues of Siva Pradeep Yanamadala

NameDINCompanyDesignation
Gowtam Manne11541781Q-Therapeutics LlpDesignated Partner
Karthik Are10538676Q-Therapeutics LlpDesignated Partner
Sriharsha Yanamadala11541780Q-Therapeutics LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Q-Therapeutics Llp
Premium access

Shareholding and investment profile for Siva Pradeep Yanamadala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Siva Pradeep Yanamadala

Siva Pradeep Yanamadala currently holds 1 directorship: Q-Therapeutics Llp (Designated Partner, since 12 Feb 2026).

Siva Pradeep Yanamadala was first appointed on 12 Feb 2026 as Designated Partner at Q-Therapeutics Llp.

The current boards of Siva Pradeep Yanamadala's companies include Gowtam Manne (Q-Therapeutics Llp), Karthik Are (Q-Therapeutics Llp), Sriharsha Yanamadala (Q-Therapeutics Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available